Nippon Chemiphar Co., Ltd.

4539.T
Drug Manufacturers - Specialty & Generic
2026/10/30 18:57 Updated
Market Cap: $34.8M (¥5.5B)
Stock Price: $9.59 (¥1,515)
Exchange Rate: 1 USD = ¥157.98

Notice Regarding Recognition of Income for Adjustment of Corporate Taxes

Recorded 137 million yen of income for adjustment of corporate taxes in the interim consolidated accounting period for the fiscal year ending March 2027. Full-year recognition is expected to be 218 million yen. Announced in the interim financial summary.

Importance:
Page Updated: October 30, 2026
IR Disclosure Date: October 30, 2026

Key Figures

  • Income for Adjustment of Corporate Taxes: 137 million yen
  • Income for Adjustment of Corporate Taxes: 218 million yen
  • Period: April 1, 2026〜September 30, 2026 (Interim consolidated accounting period)

AI要約

Key Points on Impact to Results

Nippon Chemiphar Co., Ltd. recognized 137 million yen of income for adjustment of corporate taxes in the interim consolidated accounting period for the second quarter of the fiscal year ending March 2027. This is expected to have a positive contribution to results for the period, and the full-year recognition is expected to be 218 million yen. The above is disclosed in today’s Interim Financial Summary for the fiscal year ending March 2027 [Japanese GAAP] (consolidated).

Future Disclosures and Notes

The recognition of income for adjustment of corporate taxes is based on estimates of future taxable income and assessments of recoverability of deferred tax assets. The impact on results is presented in the financial summary, and additional figures or supplementary information may be disclosed in accordance with forthcoming formal financial statements.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Nippon Chemiphar Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →